Zoology, Ecology and Pharma Advances

RATIONAL DRUG USE: CHOOSING BETWEEN GENERIC AND BRANDED MEDICINES

2026-05-28T01:26:00-04:00

Generic medications are essential for lowering medical expenses while preserving therapeutic efficacy on par with name-brand medications. With a focus on bioequivalence assessment and reporting quality, the examined publications collectively explore the scientific, regulatory, economic, and policy aspects of generic medicine use. Pharmacokinetic characteristics like area under the curve (AUC) and maximum plasma concentration (Cmax) are used in bioequivalence studies, which serve as the regulatory basis for generic medicine approval by organizations like the FDA and EMA. Nonetheless, a number of studies point out serious shortcomings in the completeness and transparency of reporting, such as the failure to adequately disclose funding sources, trial sites, randomization procedures, and regulatory requirements. Despite these limitations, the majority of trials conclude bioequivalence, supporting the clinical interchangeability of generic and innovator products

FORMULATION STRATEGIES & CHALLENGES IN PULMONRY DRUG DELIVERY

2026-05-28T01:28:43-04:00

Pulmonary drug delivery systems (PDDS) have emerged as an effective and non-invasive approach for both local and systemic drug administration, owing to the unique anatomical and physiological features of the lungs. The large alveolar surface area, thin epithelial barrier, rich vasculature, and avoidance of hepatic first-pass metabolism enable rapid onset of action, improved bioavailability, and reduced systemic side effects. Advances in particle engineering technologies—such as micronization, spray freeze-drying, and supercritical fluid techniques—have enabled the production of reparable particles with enhanced deposition in the deep lung regions. However, challenges including mucociliary clearance, enzymatic degradation, limited drug stability, and patient-dependent device handling remain critical barriers. Overall, the collective findings emphasize that continued innovations in formulation design, delivery devices, and targeting strategies are essential to fully realize the therapeutic potential of pulmonary drug delivery systems in modern drug therapy.

MIGRAINE THERAPY : CURRENT AND EMERGING TREATMENT STRATEGIES

2026-05-28T01:30:47-04:00

Migraine is a chronic, recurrent neurological disorder characterized by moderate to severe headache attacks often associated with nausea, vomiting, photophobia, and phonophobia. It affects approximately 15% of the global population and significantly impairs quality of life, work productivity, and social functioning. Migraine is classified into migraine with aura and migraine without aura, with varying pathophysiological mechanisms. Recent advances in understanding migraine neurobiology-particularly the role of calcitonin gene-related peptide (CGRP)-have transformed treatment strategies. Traditional therapies such as NSAIDs, triptans, and ergot derivatives remain widely used; however, newer therapies including CGRP monoclonal antibodies, gepants, and ditans have expanded therapeutic options. This review provides a comprehensive overview of migraine types, risk factors, pathophysiology, pharmacological and non-pharmacological treatments, newly approved therapies, limitations, challenges, and future strategies in migraine management.

EMERGING TRENDS IN HYDROGEL TECHNOLOGY FOR REGENERATIVE MEDICINE

2026-05-28T01:52:38-04:00

Hydrogels have revolutionized wound care with their unique properties, providing a moist environment that facilitates healing. These polymer-based dressings absorb wound exudates, exhibit shape adaptability, and can be modified to incorporate active compounds. Hydrogels promote wound healing by reducing inflammation, preventing infection, and enhancing tissue regeneration. They're effective for chronic wounds, burns, and surgical wounds. Advanced hydrogel technologies include smart hydrogels that respond to stimuli, injectable hydrogels for deep wounds, and antimicrobial hydrogels that prevent infection. Hydrogels can be designed to release therapeutic agents in controlled manner, promoting optimal healing. They're biocompatible, biodegradable, and non-toxic, reducing risk of adverse reactions. Hydrogels have high water content, similar to native tissues, making them ideal for dermal wound healing. Multifunctional hydrogels are a promising area of research, with potential to revolutionize wound care. They're being explored for various applications, including diabetic wounds, pressure sores, and traumatic injuries. Hydrogels can promote haemostasis, angiogenesis, and tissue regeneration, while reduce scarring and improve patient comfort. Research hydrogels are ongoing to improve their performance and expand their applications. Hydrogel-based dressings a crucial role in wound management due to unique properties. They're being used to develop advanced wound care products, including wound dressings, implantable devices, and tissue engineering scaffold.

HEALTH RISK ASSESSMENT AND TOXICITY ANALYSIS OF ELECTRONIC CIGARETTES

2026-05-28T01:55:37-04:00

Electronic cigarettes (e-cigarettes) have emerged as widely used alternatives to conventional tobacco products, particularly among adolescents and young adults, due to perceptions of reduced harm, appealing flavours, and ease of access. This review critically examines the toxicological profile of electronic cigarettes, focusing on their chemical composition, biological effects, and public health implications. E-cigarette aerosols typically contain nicotine, propylene glycol, glycerol, flavouring agents, vitamin E derivatives, and trace metals such as nickel, chromium, lead, and tin. Thermal degradation of e-liquids during heating can generate toxic aldehydes, including formaldehyde, acetaldehyde, and acrolein, which pose respiratory and cardiovascular risks. Experimental, clinical, and epidemiological evidence indicates associations between e-cigarette use and adverse outcomes such as lung injury (EVALI), oxidative stress, inflammation, endothelial dysfunction, increased cardiovascular risk, and potential carcinogenic effects. While e-cigarettes may expose users to fewer toxicants than conventional cigarettes, their long-term health effects remain insufficiently understood, especially in vulnerable populations such as adolescents and individuals with pre-existing respiratory disease.